...

METHENOLONE Enanthate 100mg/mL – Pharmaqo US

$75.00

METHENOLONE Enanthate 100mg/mL

Pharmaqo Labs

10 Ampoules X 1mL

Category:

METHENOLONE E 100mg/mL

METHENOLONE E 100mg/ml – Pharmaqo US is an injectable anabolic-androgenic steroid containing methenolone enanthate (also known as Primobolan Depot) at a concentration of 100 mg per mL, typically supplied in a 10 mL vial by Pharmaqo Labs’ US line, associated with underground performance-enhancing suppliers targeting the US market. It is a DHT-derived steroid with mild anabolic effects and low androgenic activity, primarily used off-label by bodybuilders and athletes for lean muscle preservation, fat loss, and cutting cycles without water retention or significant estrogenic side effects. Medically, it has been used to treat anemia due to bone marrow failure, muscle wasting, or osteoporosis, though it is rarely prescribed today and lacks formal approval in many regions—most use is non-therapeutic and illegal without prescription in countries like India.

How It Works

Methenolone enanthate binds to androgen receptors as a modified DHT analog, promoting protein synthesis, nitrogen retention, and collagen production for gradual lean tissue growth and recovery while minimizing fat gain. The enanthate ester ensures slow release over 10-14 days post-injection, with moderate anabolic potency (88% of testosterone) and low androgenic effects (44-57%), no aromatization to estrogen, and minimal progestogenic activity, ideal for dry, defined gains without bloating.

Dosage and Administration

  • Administered via deep intramuscular injection into large muscle groups (e.g., glutes or deltoids) using sterile technique; inject every 7-14 days due to the long half-life.
  • Non-medical bodybuilding doses: Men 400-800 mg per week (4-8 mL total), often in 8-12 week cycles; women 50-100 mg per week to minimize virilization. Beginners: 300-400 mg/week; stack with testosterone (e.g., 200-300 mg/week) for better results.
  • For the 10 mL vial (1,000 mg total): Rotate sites; monitor bloodwork for hormones, lipids, liver enzymes, and cholesterol every 4-6 weeks. Post-cycle therapy (PCT) with SERMs like clomiphene (50 mg/day for 4 weeks) starts 2 weeks after last injection to address suppression.
  • Professional oversight recommended; do not exceed 800 mg/week.

Side Effects

Common side effects include:

  • Androgenic: Mild acne, oily skin, hair loss or increased body hair (in predisposed individuals), and potential voice deepening in women.
  • Cardiovascular/Endocrine: Cholesterol shifts (decreased HDL, increased LDL), mild blood pressure rise, natural testosterone suppression (low libido, fatigue post-cycle), and injection-site irritation.

Serious risks: Liver stress (mild for injectable form, but monitor enzymes), prostate enlargement, mood alterations, hormonal imbalances, and virilization in women (clitoral enlargement, menstrual issues—potentially irreversible). Long-term use may increase cardiovascular disease or infertility risks; no estrogenic effects like gynecomastia. Discontinue for severe symptoms (e.g., jaundice, chest pain) and seek medical help.

Precautions and Warnings
  • Contraindicated in prostate/breast cancer, severe heart/liver/kidney disease, hypercalcemia, pregnancy, breastfeeding, or allergies to components (e.g., carrier oil).
  • Caution in those with high cholesterol, hypertension, diabetes (may affect glucose), or bleeding disorders; not for minors (stunted growth risk) or women beyond low dose
Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.